Annual SG&A:
$557.87M+$76.00M(+15.77%)Summary
- As of today, SRPT annual SG&A is $557.87 million, with the most recent change of +$76.00 million (+15.77%) on December 31, 2024.
- During the last 3 years, SRPT annual SG&A has risen by +$275.21 million (+97.37%).
- SRPT annual SG&A is now at all-time high.
Performance
SRPT SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$137.90M(-100.00%)Summary
- As of today, SRPT quarterly SG&A is $0.00, with the most recent change of -$137.90 million (-100.00%) on September 30, 2025.
- Over the past year, SRPT quarterly SG&A has dropped by -$128.20 million (-100.00%).
- SRPT quarterly SG&A is now -100.00% below its all-time high of $163.87 million, reached on December 31, 2024.
Performance
SRPT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$17.97B-$271.51M(-1.53%)Summary
- As of today, SRPT TTM SG&A is -$17.97 billion, with the most recent change of -$271.51 million (-1.53%) on September 30, 2025.
- Over the past year, SRPT TTM SG&A has dropped by -$18.50 billion (-3518.80%).
- SRPT TTM SG&A is now -138150.64% below its all-time high of -$13.00 million.
Performance
SRPT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
SRPT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +15.8% | -100.0% | -3518.8% |
| 3Y3 Years | +97.4% | -100.0% | -4494.3% |
| 5Y5 Years | +95.9% | -100.0% | -5837.4% |
SRPT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +97.4% | -100.0% | at low | -29.6% | at low |
| 5Y | 5-Year | at high | +97.4% | -100.0% | at low | -84.8% | at low |
| All-Time | All-Time | at high | >+9999.0% | -100.0% | at low | >-9999.0% | at low |
SRPT Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $435.40M(-22.7%) |
| Jun 2025 | - | $137.90M(+3.2%) | $563.60M(-0.2%) |
| Mar 2025 | - | $133.63M(-18.5%) | $564.50M(+1.2%) |
| Dec 2024 | $557.87M(+15.8%) | $163.87M(+27.8%) | $557.87M(+6.1%) |
| Sep 2024 | - | $128.20M(-7.6%) | $525.70M(+1.4%) |
| Jun 2024 | - | $138.80M(+9.3%) | $518.39M(+4.1%) |
| Mar 2024 | - | $127.00M(-3.6%) | $498.16M(+3.4%) |
| Dec 2023 | $481.87M(+6.7%) | $131.70M(+8.9%) | $481.87M(+2.4%) |
| Sep 2023 | - | $120.89M(+2.0%) | $470.65M(+3.5%) |
| Jun 2023 | - | $118.56M(+7.1%) | $454.54M(-7.3%) |
| Mar 2023 | - | $110.71M(-8.1%) | $490.30M(+8.6%) |
| Dec 2022 | $451.42M(+59.7%) | $120.48M(+15.0%) | $451.42M(+10.4%) |
| Sep 2022 | - | $104.79M(-32.1%) | $409.00M(+12.0%) |
| Jun 2022 | - | $154.32M(+114.8%) | $365.34M(+28.9%) |
| Mar 2022 | - | $71.84M(-8.0%) | $283.37M(+0.3%) |
| Dec 2021 | $282.66M(-11.1%) | $78.06M(+27.7%) | $282.66M(-2.7%) |
| Sep 2021 | - | $61.13M(-15.5%) | $290.65M(-4.7%) |
| Jun 2021 | - | $72.35M(+1.7%) | $304.90M(-0.4%) |
| Mar 2021 | - | $71.13M(-17.3%) | $306.24M(-3.7%) |
| Dec 2020 | $317.88M(+11.6%) | $86.05M(+14.2%) | $317.88M(+1.5%) |
| Sep 2020 | - | $75.37M(+2.3%) | $313.25M(-0.0%) |
| Jun 2020 | - | $73.69M(-11.0%) | $313.31M(+2.1%) |
| Mar 2020 | - | $82.77M(+1.7%) | $307.01M(+7.8%) |
| Dec 2019 | $284.81M(+37.1%) | $81.42M(+7.9%) | $284.81M(+6.4%) |
| Sep 2019 | - | $75.43M(+11.9%) | $267.61M(+9.1%) |
| Jun 2019 | - | $67.39M(+11.3%) | $245.22M(+9.0%) |
| Mar 2019 | - | $60.57M(-5.7%) | $224.99M(+8.3%) |
| Dec 2018 | $207.76M(+69.3%) | $64.22M(+21.1%) | $207.76M(+18.2%) |
| Sep 2018 | - | $53.04M(+12.5%) | $175.76M(+16.5%) |
| Jun 2018 | - | $47.16M(+8.8%) | $150.89M(+7.9%) |
| Mar 2018 | - | $43.34M(+34.5%) | $139.81M(+14.0%) |
| Dec 2017 | $122.68M(+51.1%) | $32.22M(+14.4%) | $122.68M(+8.2%) |
| Sep 2017 | - | $28.18M(-21.9%) | $113.40M(+5.6%) |
| Jun 2017 | - | $36.07M(+37.6%) | $107.41M(+20.6%) |
| Mar 2017 | - | $26.22M(+14.3%) | $89.09M(+10.5%) |
| Dec 2016 | $81.20M(+8.2%) | $22.94M(+3.4%) | $80.63M(-1.7%) |
| Sep 2016 | - | $22.18M(+25.0%) | $82.02M(+9.5%) |
| Jun 2016 | - | $17.75M(0.0%) | $74.92M(+6.9%) |
| Mar 2016 | - | $17.75M(-27.0%) | $70.10M(-6.6%) |
| Dec 2015 | $75.04M(+52.2%) | $24.33M(+61.2%) | $75.04M(+16.1%) |
| Sep 2015 | - | $15.09M(+16.7%) | $64.63M(+3.5%) |
| Jun 2015 | - | $12.93M(-43.0%) | $62.42M(+1.2%) |
| Mar 2015 | - | $22.70M(+63.1%) | $61.71M(+25.1%) |
| Dec 2014 | $49.31M(+56.1%) | $13.92M(+8.0%) | $49.31M(+7.7%) |
| Sep 2014 | - | $12.88M(+5.5%) | $45.80M(+11.9%) |
| Jun 2014 | - | $12.21M(+18.5%) | $40.93M(+14.4%) |
| Mar 2014 | - | $10.30M(-0.9%) | $35.77M(+13.2%) |
| Dec 2013 | $31.59M(+116.0%) | $10.40M(+29.8%) | $31.59M(+21.2%) |
| Sep 2013 | - | $8.01M(+13.6%) | $26.06M(+20.6%) |
| Jun 2013 | - | $7.05M(+15.1%) | $21.61M(+23.7%) |
| Mar 2013 | - | $6.13M(+25.9%) | $17.48M(+19.5%) |
| Dec 2012 | $14.63M(-8.9%) | $4.87M(+36.5%) | $14.63M(+12.1%) |
| Sep 2012 | - | $3.56M(+22.3%) | $13.05M(+3.0%) |
| Jun 2012 | - | $2.92M(-11.2%) | $12.67M(-7.6%) |
| Mar 2012 | - | $3.28M(-0.2%) | $13.71M(-11.3%) |
| Dec 2011 | $16.05M | $3.29M(+3.2%) | $15.46M(-0.5%) |
| Sep 2011 | - | $3.19M(-19.6%) | $15.54M(-4.0%) |
| Jun 2011 | - | $3.96M(-21.2%) | $16.19M(-19.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $5.03M(+49.4%) | $19.98M(+13.5%) |
| Dec 2010 | $14.38M(+65.4%) | $3.37M(-12.4%) | $17.60M(+23.6%) |
| Sep 2010 | - | $3.84M(-50.4%) | $14.23M(+16.7%) |
| Jun 2010 | - | $7.75M(+193.0%) | $12.19M(+83.3%) |
| Mar 2010 | - | $2.65M(>+9900.0%) | $6.65M(+6.8%) |
| Dec 2009 | $8.70M(-24.2%) | $0.00(-100.0%) | $6.23M(0.0%) |
| Sep 2009 | - | $1.80M(-18.4%) | $6.23M(+1.7%) |
| Jun 2009 | - | $2.21M(-0.6%) | $6.12M(+9.1%) |
| Mar 2009 | - | $2.22M(>+9900.0%) | $5.61M(+4.4%) |
| Dec 2008 | $11.47M(+22.9%) | $0.00(-100.0%) | $5.38M(-21.3%) |
| Sep 2008 | - | $1.70M(0.0%) | $6.83M(+2.3%) |
| Jun 2008 | - | $1.70M(-14.4%) | $6.68M(-4.8%) |
| Mar 2008 | - | $1.98M(+36.4%) | $7.01M(-24.9%) |
| Dec 2007 | $9.33M(+20.4%) | $1.45M(-5.9%) | $9.33M(-6.2%) |
| Sep 2007 | - | $1.54M(-23.9%) | $9.95M(+2.0%) |
| Jun 2007 | - | $2.03M(-52.8%) | $9.75M(+5.6%) |
| Mar 2007 | - | $4.30M(+108.1%) | $9.23M(+71.4%) |
| Dec 2006 | $7.75M(+49.6%) | $2.07M(+53.5%) | $5.39M(+13.9%) |
| Sep 2006 | - | $1.35M(-11.1%) | $4.73M(+6.6%) |
| Jun 2006 | - | $1.52M(+231.0%) | $4.43M(+5.8%) |
| Mar 2006 | - | $457.90K(-67.5%) | $4.19M(-19.1%) |
| Dec 2005 | $5.18M(+9.4%) | $1.41M(+33.9%) | $5.18M(-0.1%) |
| Sep 2005 | - | $1.05M(-17.3%) | $5.19M(+1.7%) |
| Jun 2005 | - | $1.27M(-12.2%) | $5.10M(+3.2%) |
| Mar 2005 | - | $1.45M(+2.2%) | $4.95M(+4.4%) |
| Dec 2004 | $4.74M(+3.9%) | $1.42M(+46.9%) | $4.74M(+12.6%) |
| Sep 2004 | - | $964.70K(-13.6%) | $4.21M(-12.4%) |
| Jun 2004 | - | $1.12M(-9.9%) | $4.80M(-1.3%) |
| Mar 2004 | - | $1.24M(+39.4%) | $4.86M(+6.7%) |
| Dec 2003 | $4.56M(+21.1%) | $888.40K(-43.1%) | $4.56M(+24.2%) |
| Sep 2003 | - | $1.56M(+32.5%) | $3.67M(+17.7%) |
| Jun 2003 | - | $1.18M(+26.1%) | $3.12M(+9.9%) |
| Mar 2003 | - | $933.40K(>+9900.0%) | $2.84M(-5.1%) |
| Dec 2002 | $3.76M(+12.1%) | $0.00(-100.0%) | $2.99M(0.0%) |
| Sep 2002 | - | $1.01M(+12.6%) | $2.99M(+4.6%) |
| Jun 2002 | - | $896.00K(-17.4%) | $2.86M(+7.0%) |
| Mar 2002 | - | $1.08M(>+9900.0%) | $2.67M(+4.7%) |
| Dec 2001 | $3.36M(+47.9%) | $0.00(-100.0%) | $2.55M(-23.5%) |
| Sep 2001 | - | $878.00K(+23.7%) | $3.34M(+35.7%) |
| Jun 2001 | - | $709.50K(-26.4%) | $2.46M(+40.5%) |
| Mar 2001 | - | $964.10K(+22.7%) | $1.75M(+122.7%) |
| Dec 2000 | $2.27M(+33.5%) | $785.80K(>+9900.0%) | $785.80K(>+9900.0%) |
| Sep 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1999 | $1.70M(+6.3%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1998 | $1.60M(+23.1%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1998 | - | $0.00(0.0%) | $400.00K(-42.9%) |
| Jun 1998 | - | $0.00(0.0%) | $700.00K(-36.4%) |
| Mar 1998 | - | $0.00(-100.0%) | $1.10M(-15.4%) |
| Dec 1997 | $1.30M(+116.7%) | $400.00K(+33.3%) | $1.30M(+44.4%) |
| Sep 1997 | - | $300.00K(-25.0%) | $900.00K(+50.0%) |
| Jun 1997 | - | $400.00K(+100.0%) | $600.00K(+200.0%) |
| Mar 1997 | - | $200.00K | $200.00K |
| Dec 1996 | $600.00K | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual SG&A year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM SG&A year-on-year change?
What is Sarepta Therapeutics, Inc. annual SG&A?
The current annual SG&A of SRPT is $557.87M
What is the all-time high annual SG&A for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual SG&A is $557.87M
What is Sarepta Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, SRPT annual SG&A has changed by +$76.00M (+15.77%)
What is Sarepta Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of SRPT is $0.00
What is the all-time high quarterly SG&A for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly SG&A is $163.87M
What is Sarepta Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, SRPT quarterly SG&A has changed by -$128.20M (-100.00%)
What is Sarepta Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of SRPT is -$17.97B
What is the all-time high TTM SG&A for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM SG&A is -$13.00M
What is Sarepta Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, SRPT TTM SG&A has changed by -$18.50B (-3518.80%)